HR 2130 EAS
insurance provider and documentation by a medical
practitioner licensed and registered to prescribe the
drug of the patient’s medical need for the drug. Such
information shall be available for inspection and
copying by the Attorney General.
‘‘(6) That section 310(b)(3) (relating to mail
order reporting) applies with respect to gamma hy-
droxybutyric acid to the same extent and in the same
manner as such section applies with respect to the
chemicals and drug products specified in subpara-
graph (A)(i) of such section.’’.
SEC. 5. CONTROLLED SUBSTANCES ANALOGUES.
(a) RULE
OF
CONSTRUCTION
REGARDING
CON-
TROLLED SUBSTANCE ANALOGUES.—Section 102(32) of the
Controlled Substances Act (21 U.S.C. 802(32)) is
amended—
(1) in subparagraph (A), by striking ‘‘subpara-
graph (B)’’ and inserting ‘‘subparagraph (C)’’;
(2) by redesignating subparagraph (B) as sub-
paragraph (C); and
(3) by inserting after subparagraph (A) the fol-
lowing new subparagraph (B):
‘‘(B) The designation of gamma butyrolactone or any
other chemical as a listed chemical pursuant to paragraph
(34) or (35) does not preclude a finding pursuant to sub-
HR 2130 EAS
paragraph (A) of this paragraph that the chemical is a con-
trolled substance analogue.’’.
(b) DISTRIBUTION WITH INTENT TO COMMIT CRIME
OF VIOLENCE.—Section 401(b)(7)(A) of the Controlled Sub-
stances Act (21 U.S.C. 841(b)(7)(A)) is amended by insert-
ing ‘‘or controlled substance analogue’’ after ‘‘distributing
a controlled substance’’.
SEC. 6. DEVELOPMENT OF MODEL PROTOCOLS, TRAINING
MATERIALS, FORENSIC FIELD TESTS, AND CO-
ORDINATION MECHANISM FOR INVESTIGA-
TIONS AND PROSECUTIONS RELATING TO
GAMMA HYDROXYBUTYRIC ACID, OTHER CON-
TROLLED 
SUBSTANCES, 
AND 
DESIGNER
DRUGS.
(a) IN GENERAL.— The Attorney General, in consulta-
tion with the Administrator of the Drug Enforcement Ad-
ministration and the Director of the Federal Bureau of In-
vestigation, shall—
(1) develop—
(A) model protocols for the collection of toxi-
cology specimens and the taking of victim state-
ments in connection with investigations into and
prosecutions related to possible violations of the
Controlled Substances Act or other Federal or
State laws that result in or contribute to rape,
HR 2130 EAS
other crimes of violence, or other crimes involv-
ing abuse of gamma hydroxybutyric acid, other
controlled substances, or so-called ‘‘designer
drugs’’; and
(B) model training materials for law en-
forcement personnel involved in such investiga-
tions; and
(2) make such protocols and training materials
available to Federal, State, and local personnel re-
sponsible for such investigations.
(b) GRANT.—
(1) IN GENERAL.—The Attorney General shall
make a grant, in such amount and to such public or
private person or entity as the Attorney General con-
siders appropriate, for the development of forensic
field tests to assist law enforcement officials in detect-
ing the presence of gamma hydroxybutyric acid and
related substances.
(2) AUTHORIZATION
OF
APPROPRIATIONS.—
There are authorized to be appropriated such sums as
may be necessary to carry out this subsection.
(c) REPORT.—Not later than 180 days after the date
of the enactment of this Act, the Attorney General shall sub-
mit to the Committees on the Judiciary of the Senate and
House of Representatives a report on current mechanisms
HR 2130 EAS
for coordinating Federal, State, and local investigations
into and prosecutions related to possible violations of the
Controlled Substances Act or other Federal or State laws
that result in or contribute to rape, other crimes of violence,
or other crimes involving the abuse of gamma hydroxy-
butyric acid, other controlled substances, or so-called ‘‘de-
signer drugs’’. The report shall also include recommenda-
tions for the improvement of such mechanisms.
SEC. 7. ANNUAL REPORT REGARDING DATE-RAPE DRUGS;
NATIONAL AWARENESS CAMPAIGN.
(a) ANNUAL REPORT.—The Secretary of Health and
Human Services (in this section referred to as the ‘‘Sec-
retary’’) shall periodically submit to Congress reports each
of which provides an estimate of the number of incidents
of the abuse of date-rape drugs (as defined in subsection
(c)) that occurred during the most recent one-year period
for which data are available. The first such report shall be
submitted not later than January 15, 2000, and subsequent
reports shall be submitted annually thereafter.
(b) NATIONAL AWARENESS CAMPAIGN.—
(1) DEVELOPMENT OF PLAN; RECOMMENDATIONS
OF ADVISORY COMMITTEE.—
(A) IN GENERAL.—The Secretary, in con-
sultation with the Attorney General, shall de-
velop a plan for carrying out a national cam-
HR 2130 EAS
paign to educate individuals described in sub-
paragraph (B) on the following:
(i) The dangers of date-rape drugs.
(ii) The applicability of the Controlled
Substances Act to such drugs, including
penalties under such Act.
(iii) Recognizing the symptoms that
indicate an individual may be a victim of
such drugs, including symptoms with re-
spect to sexual assault.
(iv) Appropriately responding when an
individual has such symptoms.
(B) INTENDED POPULATION.—The individ-
uals referred to in subparagraph (A) are young
adults, youths, law enforcement personnel, edu-
cators, school nurses, counselors of rape victims,
and emergency room personnel in hospitals.
(C) ADVISORY COMMITTEE.—Not later than
180 days after the date of the enactment of this
Act, the Secretary shall establish an advisory
committee to make recommendations to the Sec-
retary regarding the plan under subparagraph
(A). The committee shall be composed of individ-
uals who collectively possess expertise on the ef-
HR 2130 EAS
fects of date-rape drugs and on detecting and
controlling the drugs.
(2) IMPLEMENTATION OF PLAN.—Not later than
180 days after the date on which the advisory com-
mittee under paragraph (1) is established, the Sec-
retary, in consultation with the Attorney General,
shall commence carrying out the national campaign
under such paragraph in accordance with the plan
developed under such paragraph. The campaign may
be carried out directly by the Secretary and through
grants and contracts.
(3) EVALUATION BY GENERAL ACCOUNTING OF-
FICE.—Not later than two years after the date on
which the national campaign under paragraph (1) is
commenced, the Comptroller General of the United
States shall submit to Congress an evaluation of the
effects with respect to date-rape drugs of the national
campaign.
(c) DEFINITION.—For purposes of this section, the
term ‘‘date-rape drugs’’ means gamma hydroxybutyric acid
and its salts, isomers, and salts of isomers and such other
drugs or substances as the Secretary, after consultation with
the Attorney General, determines to be appropriate.
HR 2130 EAS
SEC. 8. SPECIAL UNIT IN DRUG ENFORCEMENT ADMINIS-
TRATION FOR ASSESSMENT OF ABUSE AND
TRAFFICKING OF GHB AND OTHER CON-
TROLLED SUBSTANCES AND DRUGS.
(a) ESTABLISHMENT.—Not later than 60 days after
the date of the enactment of this Act, the Attorney General
shall establish within the Operations Division of the Drug
Enforcement Administration a special unit which shall as-
sess the abuse of and trafficking in gamma hydroxybutyric
acid, flunitrazepam, ketamine, other controlled substances,
and other so-called ‘‘designer drugs’’ whose use has been as-
sociated with sexual assault.
(b) PARTICULAR DUTIES.—In carrying out the assess-
ment under subsection (a), the special unit shall—
(1) examine the threat posed by the substances
and drugs referred to in that subsection on a national
basis and regional basis; and
(2) make recommendations to the Attorney Gen-
eral regarding allocations and reallocations of re-
sources in order to address the threat.
(c) REPORT ON RECOMMENDATIONS.—
(1) REQUIREMENT.—Not later than 180 days
after the date of the enactment of this Act, the Attor-
ney General shall submit to the Committees on the
Judiciary of the Senate and House of Representatives
a report which shall—
HR 2130 EAS
(A) set forth the recommendations of the
special unit under subsection (b)(2): and
(B) specify the allocations and reallocations
of resources that the Attorney General proposes
to make in response to the recommendations.
(2) TREATMENT OF REPORT.—Nothing in para-
graph (1) may be construed to prohibit the Attorney
General or the Administrator of the Drug Enforce-
ment Administration from making any reallocation
of existing resources that the Attorney General or the
Administrator, as the case may be, considers appro-
priate.
SEC. 9. TECHNICAL AMENDMENT.
Section 401 of the Controlled Substances Act (21
U.S.C. 841) is amended by redesignating subsections (d),
(e), (f), and (g) as subsections (c), (d), (e), and (f), respec-
tively.
Amend the title so as to read: ‘‘An Act to amend the
Controlled Substances Act to direct the emergency sched-
uling of gamma hydroxybutyric acid, to provide for a na-
tional awareness campaign, and for other purposes.’’.
Attest:
Secretary.
HR 2130 EAS——2
HR 2130 EAS——3
HR 2130 EAS——4
HR 2130 EAS——5